Cargando…

Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19

BACKGROUND: Lianhua Qingwen Capsules (LHQW) is a traditional Chinese medicine prescription commonly used to treat viral influenza in China. There has been sufficient evidence that LHQW could effectively treat COVID-19. Nevertheless, the potential anti-(mutant) SARS-CoV-2 and anti-inflammation compou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Liang, He, Min, Li, Shaoping, Zhao, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261255/ https://www.ncbi.nlm.nih.gov/pubmed/35799189 http://dx.doi.org/10.1186/s13020-022-00637-0

Ejemplares similares

Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity
por: Zhou, Yongfeng, et al.
Publicado: (2021)

The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule
por: Shen, Xuhui, et al.
Publicado: (2021)

Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
por: Chen, Shuaishuai, et al.
Publicado: (2021)

Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study
por: Lu, Yun, et al.
Publicado: (2023)

The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis
por: Hu, Caiyun, et al.
Publicado: (2022)

Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule
por: Lan, Xiao-fang, et al.
Publicado: (2021)

Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study
por: Xu, Xiangru, et al.
Publicado: (2023)

Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019
por: Wang, Deng-chao, et al.
Publicado: (2022)

Efficacy and Safety of Chinese Medicine Lianhua Qingwen for Treating COVID-19: An Updated meta-Analysis
por: Li, Yapeng, et al.
Publicado: (2022)

Qualitative and Quantitative Analysis of the Major Constituents in Chinese Medical Preparation Lianhua-Qingwen Capsule by UPLC-DAD-QTOF-MS
por: Jia, Weina, et al.
Publicado: (2015)

Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS
por: Fu, Shuai, et al.
Publicado: (2021)

Deciphering suppressive effects of Lianhua Qingwen Capsule on COVID-19 and synergistic effects of its major botanical drug pairs
por: CHEN, Yuanyuan, et al.
Publicado: (2023)

An umbrella review of Lianhua Qingwen combined with Western medicine for the treatment of coronavirus disease 2019
por: Yang, Kelu, et al.
Publicado: (2022)

Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19
por: Xia, Qi‐Dong, et al.
Publicado: (2020)

Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
por: Li, Liu-Cheng, et al.
Publicado: (2020)

A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
por: Zhuang, Jieqin, et al.
Publicado: (2021)

Lianhua Qingwen Capsules Reduced the Rate of Severity in Patients with COVID-19: A System Review and Meta-Analysis of Randomized Controlled Trials
por: Shi, Chengqian, et al.
Publicado: (2022)

Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model
por: Yang, Chunguang, et al.
Publicado: (2020)

Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Sun, Xiao-hu, et al.
Publicado: (2022)

Intestinal microbiota analysis and network pharmacology reveal the mechanism by which Lianhua Qingwen capsule improves the immune function of mice infected with influenza A virus
por: Xu, Ping, et al.
Publicado: (2022)

Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis
por: Hu, Caiyun, et al.
Publicado: (2020)

Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study
por: Qiao, Yunfeng, et al.
Publicado: (2023)

Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach
por: Yang, Ruhao, et al.
Publicado: (2021)

Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials
por: Zeng, Mengjie, et al.
Publicado: (2020)

Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial
por: Xiao, Mingzhong, et al.
Publicado: (2020)

Traditional Chinese medicine Lianhua Qingwen for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials
por: Li, Shasha, et al.
Publicado: (2021)

Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival
por: Cao, Jun-Feng, et al.
Publicado: (2022)

Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]
por: Hu, Ke, et al.
Publicado: (2022)

Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of “Different Diseases with the Same Treatment” Based on Network Pharmacology
por: Su, Huihui, et al.
Publicado: (2022)

The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis
por: Zhang, Qiongshuai, et al.
Publicado: (2020)

Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis
por: Liu, Nanyang, et al.
Publicado: (2020)

Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19
por: Li, Liyuan, et al.
Publicado: (2022)

A Meta-Analysis of 13 Randomized Trials on Traditional Chinese Medicine as Adjunctive Therapy for COVID-19: Novel Insights into Lianhua Qingwen
por: Lei, Yi, et al.
Publicado: (2022)

Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial
por: Zhan, Yang-Qing, et al.
Publicado: (2023)

Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis
por: Zhang, Xiaolin, et al.
Publicado: (2020)

Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection
por: Gao, Dan, et al.
Publicado: (2020)

Natural tannins as anti-SARS-CoV-2 compounds
por: Wang, Shao-Chun, et al.
Publicado: (2022)

Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
por: Yu, Pei-Chen, et al.
Publicado: (2022)

Identification and characterization of the anti-SARS-CoV-2 activity of cationic amphiphilic steroidal compounds
por: Borin, Alexandre, et al.
Publicado: (2022)

In Search of Herbal Anti-SARS-Cov2 Compounds
por: Matveeva, Tatiana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nkpkscrnfmnk5cu8vm4kjqq9g9